Filing identity and reporting period
The supplied filing is SG Blocks, Inc. (Nasdaq: SGBX), not Olenox Industries Inc. It is an unaudited Form 10-Q for the quarter and six months ended June 30, 2022, filed August 15, 2022. Confirm the filing matches the intended company before relying on this summary.
Business context
SG Blocks provides modular building products, construction and engineering services, and medical testing-related services. Its operations include construction, medical, development, and corporate activities. Medical revenue is primarily associated with COVID-19 testing and related products and services.
Financial performance
| Metric | Three months ended June 30, 2022 | Six months ended June 30, 2022 | Comparable 2021 period |
|---|---|---|---|
| Revenue | $7.55 million | $16.16 million | $11.85 million quarter; $21.04 million six months |
| Gross profit / margin | $0.77 million / about 10% | $3.26 million / about 20% | $2.01 million / about 17% quarter; $2.42 million / about 11% six months |
| Operating income (loss) | $(1.33) million | $(0.91) million | $0.08 million quarter; $(1.09) million six months |
| Net income (loss), consolidated | $(1.02) million | $(0.52) million | $0.15 million quarter; $(0.99) million six months |
| Net loss attributable to SG Blocks common stockholders | $(1.42) million; $(0.11) per share | $(2.13) million; $(0.16) per share | $(1.54) million; $(0.17) per share quarter; $(3.58) million; $(0.41) per share six months |
Quarterly revenue fell 36%, mainly because medical revenue declined $6.47 million, partly offset by growth in construction, particularly office projects. Six-month revenue fell 23%, as medical revenue declined $5.54 million while construction services increased. Six-month gross margin improved from 11% to 20%, which management attributed largely to prior-year losses on a legacy SG Echo contract. Second-quarter margin weakened year over year; management cited a large contract that generated only $32,459 gross profit on $3.72 million of quarterly revenue.
Other income was $372,407 for the quarter and $491,309 for the six months, primarily reflecting escrow funds from the SG Echo acquisition. Six-month interest expense was $121,975 versus $692 in 2021, largely due to debt entered into in 2021. No income tax expense or benefit was recorded.
Cash flow, liquidity, and debt
Cash and cash equivalents were $2.43 million at June 30, 2022, down from $13.02 million at December 31, 2021. For the first six months, operating cash use was $5.36 million, investing cash use was $3.08 million, and financing cash use was $2.16 million; cash decreased by $10.60 million. Operating cash use rose from $1.31 million in the comparable 2021 period, with working-capital movements including a $4.00 million bond escrow deposit and a $3.04 million reduction in accounts payable and accrued expenses.
Current assets were $15.19 million and current liabilities $8.72 million. Current assets include $4.00 million of bond escrow and $4.39 million of assets held for sale; the company reported that $2.00 million of escrow was returned in July 2022 and expected the balance in the quarter ending September 30, 2022. Management said cash should last at least 12 months, but also disclosed that funding is not secured and additional capital may be needed. The filing’s risk factors state that continued losses and financing uncertainty raise substantial doubt about the company’s ability to continue as a going concern.
Reported notes payable included approximately $2.00 million of current short-term borrowing and a $750,000 non-interest-bearing forgivable note, subject to default and employment conditions. Lease liabilities totaled approximately $2.79 million. The company reported no material off-balance-sheet arrangements.
Outlook, commentary, and risks
- Construction backlog was $4.18 million at June 30, up from $3.22 million at year-end. Management expected it to convert to revenue by December 31, 2022. Backlog includes an ATCO contract signed for $5.95 million, and the filing cautions that contracts may be cancelled, deferred, or changed and that backlog does not assure revenue or profit.
- COVID-related supply-chain disruptions, labor shortages, project delays, and inflation-related construction cost increases remain risks; the duration and financial impact are uncertain.
- Customer concentration is significant: two customers generated about 90% of six-month revenue, and two accounted for 79% of gross receivables at period-end.
- Potential dilution includes 757,450 restricted stock units, 36,436 options, and 2,025,520 warrants outstanding. The October 2021 Series A warrants have a $4.80 exercise price.
- Material litigation includes the HOLA project dispute, Pizzarotti litigation, and an Osang Healthcare case. The company stated it could not predict possible losses or recoveries and recorded no provision for these matters. The EDI cross-claims were settled for $67,126; the company’s separate claim continued.
- On July 5, 2022, CEO Paul Galvin’s annual base salary was amended to $500,000. Disclosure controls were reported effective, with no material change in internal control over financial reporting identified for the quarter.
Most important facts for investors to verify
- Confirm that SG Blocks’ 10-Q—not an Olenox filing—is the intended document.
- Track the timing and return of the $4.00 million bond escrow and the company’s cash burn against its 12-month liquidity assertion.
- Assess whether the $4.18 million backlog converts as expected and whether the large ATCO contract can produce adequate margins.
- Review medical-revenue dependence, customer concentration, and the effect of lower testing activity.
- Monitor financing needs, going-concern disclosures, outstanding warrants and equity awards, and updates on material litigation.